INTRODUCTION
Glucuronidation is a major pathway for the inactivation and excretion of both endobiotic compounds such as bilirubin and steroids as well as a multitude of xenobiotic compounds including drugs, carcinogens and others environmental pollutants [1] . In the past decade it has been established by substrate specificity, ontological, induction, purification and cloning studies that these glucuronidation reactions are catalysed by a multigene family of membrane-bound enzymes the UDP-glucuronosyltransferases (UGTs; EC 2.4.1.17) located in the endoplasmic reticulum [2] . Recently several human UGT cDNAs have been cloned and, on the basis of evolutionary divergence, have been split into two families termed UGT1 and UGT2 [3] . A single UGTI gene on chromosome 2 encodes human phenol and bilirubin UGTs [4, 5] . The gene comprises at least six different exon I s which encode the substrate-binding domains of the different isoforms, and exons 2-5 which encode the identical C-terminals of the UGT1 isoforms [4] . It is predicted that each exon 1 is differentially spliced to the exon 2 to 5 cluster in the primary RNA transcript to result in the formation of two bilirubin (UGTl * and UGT1*4) and two phenol (UGT1*02 and UGT1*6) UGT isoforms [3] . The UGT2 gene family, which contains odorantand steroid-metabolizing isoforms, in contrast with the UGT1 family is composed of independent genes [6, 7] which are clustered on human chromosome 4 [8] .
The most important physiological role of UGTs is the esterification of at least one of the two propionic acid side chains of the toxic haem breakdown product bilirubin, which is essential for the efficient biliary excretion of bilirubin. Failure to carry out this important task in humans results in potentially fatal consequences manifested in the inborn error Crigler-Najjar syndrome type 1 [9] . Although UDP-glucuronic acid (UDPGA) is such as phenols, anthraquinones and flavones (many of which are in foodstuffs) were glucuronidated by the enzyme. The enzyme also had the capacity to glucuronidate oestriols and oestradiols sterioselectively. H.p.l.c. analysis of the regioselective glucuronidation of ,-oestradiol (E2) demonstrated that it was conjugated solely at its A-ring hydroxy group by the bilirubin UGT to form E2-3-glucuronide, this was in contrast with human liver microsomes which formed 3-and 17-glucuronides of this oestrogen. Studies utilizing microsomes from a Crigler-Najiar patient and inhibition of E2 glucuronidation with bilirubin indicated that the cloned expressed bilirubin UGT was the major human UGT isoform responsible for the formation of E2-3-glucuronide, which is the predominant E2 conjugate in human urine.
the primary UDP-sugar co-substrate utilized for the esterification in mammals two other UDP-sugars, UDP-glucose and UDPxylose, have also been demonstrated to be potential co-substrates [10] . Toxicologically it is important to determine whether exogenous compounds present in our diet, drugs or pollutants interact with bilirubin UGTs. The substrate specificity ofbilirubin UGTs has received scant attention; only five compounds in addition to bilirubin are known as substrates for the enzymes [11] [12] [13] [14] . Indirect evidence suggests that bilirubin UGTs may also interact with several other compounds which may be substrates, as administration or exposure to the xenobiotics ethinyloestradiol [15] and novobiocin [16] in humans causes elevated bilirubin levels and jaundice. Previously we have reported the cloning and stable expression of a cDNA encoding the major constitutive human bilirubin UGT, termed UGT1 * 1, in a fibroblast cell line [12] . In this report we utilize the cloned expressed human bilirubin UGT to study the kinetics and the formation of bilirubin conjugates using three different UDP-sugars and comprehensively assess the substrate specificity of the enzyme with over 100 different endogenous and exogenous compounds with UDPGA as a sugar donor.
MATERIALS AND METHODS
Maintenance of the genetically engineered cell line and preparation of cell extracts Hamster lung fibroblast V79 cells stably expressing UGT1*1 (formerly termed HP3) cDNA [12] 
Liver samples
Human liver samples were obtained with ethical permission from a normal subject and a Crigler-Najar patient (Bi) as described previously [17] .
Protein estimation
Protein estimations were carried out essentially as described by the procedure of Lowry et al. [18] with BSA fraction V (Boehringer-Mannheim, U.K.) as standard.
Enzyme assays
Substrates, as well as other chemicals, were purchased from Sigma (Poole, Dorset, U.K.), Aldrich (Dorset, U.K.), BDH (Poole, Dorset, U.K.) or Fluka (Derbyshire, U.K.) and were the highest grade available.
For the quantification of total bilirubin conjugates and percentages of bilirubin mono-and di-conjugate formation two sets of assays were run in parallel. One set was used to estimate specific activity of bilirubin UGT as described by Heirwegh et al. [19] and the other set was analysed by h.p.l.c. to separate mono-and di-conjugates as described by Odell et al. [20] RESULTS AND DISCUSSION Study of the kinetics of formation of bilirubin mono-and diconjugates
The excretion of the toxic haem breakdown product bilirubin from the body is of paramount importance [2, 9] . In human bile bilirubin glucuronides predominate; however, biliary bilirubin xylosides and glucosides have also been identified [23, 24] . Whereas the UDP-sugar specificity of bilirubin UGT has been studied in purified rat liver preparations [25] because of the lability of the human enzyme and scarcity of tissue this has not been characterized is humans apart from in crude liver homogenates [10, 26] .
Studies by Motoyama [26] V.ax. with UDPGA was -20 % higher compared with that with UDP-xylose at saturating UDP-sugar concentration ( Table 1) . The ratio of transfer rates of glucuronosyl: xylosyl: glucosyl with saturating amounts of substrates by the cloned expressed enzyme was 1:0.8:0.1 which is close to that found by Fevery et al. [10] for human liver homogenates (1:0.6:0.07), suggesting that this isoform is the major enzyme responsible for the biosynthesis of the different types of bilirubin conjugates found in bile. As there is a less than 2-fold difference in the catalytic potential of the enzyme to utilize UDPGA and UDP-xylose as sugar donors this suggests that as the levels of bilirubin glucuronides in bile are more than 20-fold greater than bilirubin xylosides [23, 24] UDPxylose must be present at very low levels in human liver in comparison with UDPGA levels.
The rate of formation of bilirubin glucuronides and xylosides enabled the accurate quantification of mono-and di-conjugates over a 30 min time course (Figures la and ld) . These results indicated that a single bilirubin UGT enzyme was able to catalyse the formation of both mono-and di-conjugates of bilirubin using UDPGA and UDP-xylose as co-substrates. The low catalytic rate measured for UDP-glucose prevented the quantification of mono-and di-glucosides. The conjugation of bilirubin in the presence of either UDPGA or UDP-xylose in the assay system was linear during the 30 min incubation time. The time-course experiments demonstrated that there were only slight differences in the proportion of bilirubin monogluronides and bilirubin diglucuronides (40-60% over the entire incubation period) formed during 30 min incubation, indicating that the hydrophilic monoglucuronidated bilirubin was rapidly conjugated by the enzyme (Figure la) . In contrast, by following the time course of formation of bilirubin xylosides we found that monoxylosides were the predominant conjugate formed throughout the time course, indicating that they were only slowly converted into dixylosides by the enzyme (Figure ld) . This data suggests that the enzyme has different affinities for the two monoconjugated species.
Increasing the concentration ofbilirubin or UDP-sugar utilized in the assay system changed the relative amounts of bilirubin mono-and di-conjugates formed with both UDPGA and UDPxylose. At low concentrations of bilirubin (10-50 SM) the The results obtained by varying either bilirubin or UDP-sugar may reveal the situation in vivo. The plasma level of bilirubin is always maintained at a very low concentration (< 17 ,M) to avoid any hazardous effect of free bilirubin, such as kernicterus [9] . In this study we have shown that at physiological concentrations of bilirubin and UDPGA (0.5 mM) [1, 9] , the formation of bilirubin diglucuronides predominated, which reflects the in vivo situation where more than 80 % of the bilirubin conjugates in bile are bilirubin diglucuronides [24] .
Ex vivo conjugation of bilirubin in fibroblast cells expressing Studies with different concentrations of UDP-sugars were also carried out to determine the effect on bilirubin conjugation.
When bilirubin was added to the medium of fibroblast cells heterologously expressing the human bilirubin transferase, bilirubin glucuronides could be detected in the culture medium after 3 h and accumulated during the 18 h course of the experiment (Figure 2 ). H.p.l.c. analysis revealed the formation of both mono-and di-glucuronides ( Figure 2) . No xylosides or glucosides were detected indicating that the levels of UDP-xylose and UDP-glucose must be absent or very low in comparison with UDPGA levels, or that transport processes are not present in this cell line for their excretion.
This demonstrated that as well as the in vitro conjugation of bilirubin the genetically engineered cell line expressing the bilirubin UGT was capable of ex vivo uptake and metabolism of bilirubin and the transport of bilirubin glucuronides out of the cell (Figure 2 ), suggesting it may be a good model for studying the transport of bilirubin and its conjugates. (Tables 2-6 ). Six compounds were glucuronidated at higher rates than bilirubin using the conditions employed.
(a) Xenobiotics as substrates of human bilirubin UGT Thirteen xenobiotic phenols were glucuronidated by the enzyme (Table 2) . Polyphenolic gallates, which are used as food additives due to their antioxidant properties [27] , were the most rapidly conjugated of substrates by the enzyme being 2-5-fold higher than the rate with bilirubin when measured at substrate concentrations of 500 ,IM (Tables 1 and 2 (Table 2 ). The enzyme was also demonstrated to have a preference for the conjugation of the hydroxy group at carbon 1 of naphthols rather than carbon 2 which was conjugated at a 2-fold lower rate. Unlike other enzymes of the UGT1 family [22] the human bilirubin UGT was unable to catalyse the glucuronidation of phenols with alkyl substituents ortho to the phenolic hydroxy group, such as carvacrol or thymol, nor had it the ability to conjugate aliphatic alcohols (citronellol or nopol) ( Table 3) . Carboxylic acid drugs (fenoprofen, suprofen) or phthaleides (phenolphthalein, eosin), which are good substrates for several UGT2 enzymes [27, 28] , were not glucuronidated by bilirubin UGT either (Table 3 ). The 45 drugs and medicinal compounds listed in Table 3 , many of which are extensively glucuronidated in humans [2] , were not substrates for the enzyme using the conditions employed.
Comparison of the structures of the three anthraquinones anthraflavic acid, emodin and alizarin, which were substrates for the enzyme, with anthrarufin, 1,8-dihydroxyanthraquinone, chrysophanic acid and quinizarin, which were not substrates, gave an insight into the structure; of anthraquinones accepted as substrates for the enzyme (Table 4) . Hydroxy groups at positions 2, 3 and 6 of the anthraquinone structure appeared to be accessible to enzymic conjugation with glucuronic acid whereas hydroxy groups closer to the quinoic carbonyl oxygens at positions 1, 4 or 8 appeared not to be accessible. Such a result might be explained by steric hinderance or an interaction of the hydroxy groups with the carbonyl groups. The reason for anthraflavic acid being more rapidly glucuronidated than emodin and alizarin might in part be due to the fact that it has two hydroxy groups in preferred positions (positions 2 and 6) for conjugation, thus it may be diconjugated.
Examination of the different flavones glucuronidated indicated that quercetin, fisetin and naringenin, which have hydroxy groups at the R2 position (Table 4) , were conjugated at higher rates. The reason why 3-hydroxyflavone was glucuronidated at a 4-fold higher rate than galangin (3,5,7-dihydroxyflavone) is difficult to interpret, indicating the complexity of the structural and/or electronic configuration of flavones that govern their rates of glucuronidation. Obviously the use of more structural analogues may help solve such apparent anomalies.
As the highest glucuronidation rate by the transferase among the substrates tested was with octylgallate, which was also a good substrate for phenol UGT1 *02 (formerly termed HP4) [22] , this compound was used in a series of experiments to determine the kinetics of octylgallate glucuronidation and to indicate which enzyme might assume major responsibility for catalysis of glucuronidation of this substrate in vivo. The kinetic parameters of bilirubin and a bulky phenol UGT towards octylgallate were compared ( Table 5 ). The catalytic potential (Vmax./Km(0cty1ga11ate) x Vmax/Km(UDPGA) of the bulky phenolmetabolizing isoform was approx. 40-fold higher compared with the bilirubin isoform. This suggests that the bilirubin isoform is unlikely to play an important role in the glucuronidation of octylgallate in vivo.
(b) Steroids and other endogenous compounds as substrates of human bilirubin UGT Previously we have demonstrated that this human bilirubin UGT is the major enzyme responsible for the glucuronidation of the oral contraceptive drug ethinyloestradiol at the 3-OH position in human liver [13] . In this study we also assessed the ability of the enzyme to glucuronidate endogenous steroids ( Table 6 ). The corticoids, corticosterone and aldosterone, and the androgen testosterone were not substrates for the enzyme (Table 3) . Of the 17 steroids tested only four that had both 17/3-and 3,3-hydroxy substituents were glucuronidated (Tables 3 and 6 ). This suggests that hydroxy moities at these positions are necessary structural requirements for steroids to fit the active site of the enzyme. Besides hydroxy groups at C-3 and C-17, the stereochemistry of hydroxy groups at C-16 and C-17 in oestriols also affected glucuronidation (Table 6 ). The hydroxy group had to be in the fl-position at C-17 and the a-position at C-16 for the oestrogen to be glucuronidated. To [34] . In human urine fl-oestradiol glucuronides account for 12-36 % of the total oestrogens excreted and the 3-glucuronide was the predominant conjugate [35] . Until now the regioselective glucuronidation of p3-oestradiol by human liver enzyme preparations in vitro has not been studied, this i therefore prompted us to study the process in more detail utilizing the cloned enzyme and human liver microsomes. H.p.l.c. analysis using a system that separated E2 glucuronide isomers indicated that the glucuronide synthesized by incubating E2 with the bilirubin UGT had a retention time identical with an authentic E2-3-glucuronide standard (Figures 3a and 3b) , representing conjugation at the phenolic hydroxy group of the A-ring as opposed to the aliphatic 17-hydroxy position on the D-ring. As expected from the in vivo studies human liver microsomes had the capacity to form both the 3-and 17-glucuronides, the E2-3-glucuronide: E2-1 7fl-glucuronide ratio being 1.2 (Figure 3c ). The authenticity of the glucuronides formed was further confirmed by ,3-glucuronidase treatment, which abolished the peaks (results not shown). The use of Crigler-Najar liver microsomes, which are genetically devoid of bilirubin UGT activity [9] , or the addition of bilirubin to an incubation with /,-oestradiol and normal human liver microsomes, resulted in a decreased formation of the E2-3-glucuronide such that the E2-3-glucuronide: E2-177,-glucuronide ratio was 0.30 and 0.45 respectively (Figures 3d and 3e ). This suggested that bilirubin UGT was the enzyme responsible for the majority of the E2-3-glucuronide formation in human liver. It is therefore interesting to speculate that bile ductular cholestasis which has been described in several Crigler-Najjar patients [9] might be due to the genetic deficiency of bilirubin UGT which results in the formation of mainly cholestatic E2-17,/-glucuronide (Figure 3d) rather than the non-cholestatic E2-3-glucuronide as in normal humans [36] .
In addition to steroids several other endogenous compounds such as neurotransmitters and bile acids, which are substrates for other UGT isoenzymes [2] , were not substrates of the bilirubin transferase (Table 3 ).
Conclusions
We conclude that human bilirubin UGT is the major UGT isoform responsible for the glucuronidation, xylosidation and glucosidation of bilirubin in human liver. Previously we have shown that human bilirubin UGT is involved in thyroid hormone and ethinyloestradiol glucuronidation. In this report we also show that it is capable of the glucuronidation of endogenous oestrogens (/3-oestradiol and oestriols) and a diverse variety of xenobiotic compounds (phenols, anthraquinones and flavones) of which many are found in our diet, e.g. eugenol (cloves), gallates (food preservatives), emodin (rhubarb) and naringenin (grapefruit), indicating the functional diversity of this enzyme. This suggests that these compounds have the potential to cause jaundice (hyperbilirubinaemia) by acting as competitive substrates with the major endogenous substrate bilirubin for the active site of the enzyme. Further study of structural analogues by kinetic analysis should lead to a better description of the substrate-binding site of this important enzyme.
